Pharmaceutical Supply Chain Transparency Legislation

April 14 – April 16, 2026

Lawmakers have introduced the Drug Origin Transparency Act of 2026 and the CLEAR LABELS Act to mandate that pharmaceutical companies disclose the original manufacturers and ingredient suppliers on medicine labels.

Policies

Rep. Matsui Introduces Bipartisan Bill to Require Drug Makers to Disclose Ingredient Sources

H.R. 8339

McCormick and DeLauro Introduce CLEAR LABELS Act to Track Drug Ingredients

H.R. 8269

Senate CLEAR LABELS Act Would Require Drug Labels to Show Where Medicines Are Made

S. 3788

Analysis generated by AI. Always verify with official sources.